Axxess Pharma Inc. Announces Launch of New TapouT Product 'TapouT Extreme Muscle'
Axxess Pharma Inc. Announces Launch of New TapouT Product 'TapouT Extreme Muscle'
TORONTO, ON--(Marketwired - Jan 14, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., a new product set to be launched through on-line and retail channels. TapouT Extreme Muscle, a product under development for the past six months, is a powerful new supplement that combines the best natural ingredients for today's active men.
TapouT Extreme Muscle naturally boosts testosterone levels which builds muscle, burns fat and enhances the libido. The formula is supported with fat-burning, energizing ingredients and powerful nitric oxide pre-cursors. The ingredients combine to create a new world-class supplement that has already created buzz and excitement within the professional sporting community.
Dr. Bagi, President of Axxess Pharma stated: "This exciting new product is in line with our strategy of offering new products which can optimize Quality of Life through targeted natural ingredients. We expect to be in production within the next two weeks, and have the product available online and in retail stores by February."
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, - to optimal health management through improved nutritional supplements.
For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.
Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.
Contact:
Investor Relations
Taylor Capitol, Inc.
Stephen Taylor
(973) 351-3868
STEPHTAYL9@AOL.COM
www.TheStockAlerts.com
Axxess Pharma Inc. Announces Launch of New TapouT Product 'TapouT Extreme Muscle'
TORONTO, ON--(Marketwired - Jan 14, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE) a specialty pharmaceutical and nutritional supplements company is pleased to announce through its wholly-owned subsidiary, AllStar Health Brands Inc., a new product set to be launched through on-line and retail channels. TapouT Extreme Muscle, a product under development for the past six months, is a powerful new supplement that combines the best natural ingredients for today's active men.
TapouT Extreme Muscle naturally boosts testosterone levels which builds muscle, burns fat and enhances the libido. The formula is supported with fat-burning, energizing ingredients and powerful nitric oxide pre-cursors. The ingredients combine to create a new world-class supplement that has already created buzz and excitement within the professional sporting community.
Dr. Bagi, President of Axxess Pharma stated: "This exciting new product is in line with our strategy of offering new products which can optimize Quality of Life through targeted natural ingredients. We expect to be in production within the next two weeks, and have the product available online and in retail stores by February."
About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, - to optimal health management through improved nutritional supplements.
For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.
Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.
Contact:
Investor Relations
Taylor Capitol, Inc.
Stephen Taylor
(973) 351-3868
STEPHTAYL9@AOL.COM
www.TheStockAlerts.com
